Manufacturing Chemist Interview: Alistair Hay Head of Peptide Business and Process Development
From dark art to an age of enlightenment
Dr Kevin Robinson sits down with Almac Sciences’ Alistair Hay to discuss the recent happenings in Almac’s GMP peptides business, in terms of growth, development and strategic operations. They also discuss the company’s current focus on neoantigen-derived vaccines that harness the body’s own immune system to fight cancer.
Read the full article below
Almac API, Chemical Development, Analytical & Solid State Services
Almac Sciences provides integrated services from development to commercial scale of advanced intermediates and Active Pharmaceutical Ingredients (API).
We provide a range of services for small molecules (including highly potent) and peptides. We have a proven track record of saving time and cost through the integration of our services and application of innovative biocatalysis and technology solutions.
We offer a full suite of analytical testing for a range of different product types including small molecules, peptides, biologics, conjugates, potent and controlled substances.
Our vast pool of scientific knowledge can help to overcome the analytical challenges that typically arise during drug development.
